Wj. Hubbard et al., Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques, HUMAN IMMUN, 62(5), 2001, pp. 479-487
T-cell reduction utilizing specific antibody has been widely used in human
transplantation, and is a cornerstone of several tolerance induction strate
gies in nonhuman primates. We have established a population of long-term to
lerant rhesus macaques induced with an anti-CD3 epsilon immunotoxin (IT). T
his treatment effects transient, specific and profound ablation of T cells
in blood and lymphoid tissues. Tn most instances the IT was used in combina
tion with the NF-kappaB inhibitor, 15-Deoxyspergualin. This 2-week long pro
tocol produces a "window of opportunity" for tolerization in which the anim
al exhibits an enduring quiescent state of unresponsiveness to the allograf
t, all accomplished without maintenance immunosuppressive drugs. During thi
s induction period, the treated immune system bears some resemblance to tha
t of the neonate, in that T cell numbers are abnormally low and antigen pre
sentation by dendritic cells is precluded by an arrest in their NF-kappaB d
ependant maturation. In addition, IL-4 production is prominent during and a
fter the tolerance induction interval. For this study we focused on measuri
ng the monkey's ability to repopulate T cells with particular emphasis on t
he memory T-cell phenotype. Three "memory" phenotypes were utilized; CD3(+)
CD45RO(+), CD3(+)CRTH2(+), and CD3(+)CD4(+)CD8(+). All three phenotypes exh
ibited different patterns of recovery, all of which included transient burs
ts in their numbers during repopulation. We also estimated thymic activity
after T-cell ablation with the use of a newly-described RTE or recent thymi
c emigre phenotype (a naive CD8(+)CD103(+) T cell). This marker revealed pr
oduction of RTE cells including supranormal levels at approximately 6 month
s post-transplant, implicating thymic function in the repopulation of T-cel
ls. Finally, we measured antibody responses to a panel of antigens (vaccine
s, environmental antigen, and foreign proteins) that indicated there was no
apparent loss of immunologic function during or after the tolerance induct
ion period. Results of studies of T-cell receptor repertoire expression sug
gest preservation of the pretreatment repertoire, which is consistent with
rapid recovery of immune competence to the test antigens. Taken together, t
hese results suggest that while aggressive, this tolerance induction proroc
ol does not appear to incur a prolonged immunologically-compromised state,
if at all. (C) American Society for Histocompatibility and Immunogenetics,
2001. Published by Elsevier Science Inc.